|
| Number | Study | Kind of stem cells | Method | Conditions | Status | Trial institution/sponsor and country | NCT number and duration period |
|
| 1 | “Stem Cell Educator Therapy in Alopecia Areata” | Cord blood-derived multipotent stem cells (CB-SCs) | A closed loop system that circulates a patient’s blood through a blood cell separator, briefly cocultures the patient’s lymphocytes with adherent CB-SCs in vitro, and returns the educated lymphocytes (but not the CB-SCs) to the patient’s circulation | Alopecia areata | UKN | The First Hospital of Hebei Medical University Shijiazhuang, Hebei, China | NCT01673789 2012-2013 |
| 2 | “The Effect of Allogeneic Human Adipose Derived Stem Cell Component Extract on Androgenic Alopecia” | Allogeneic human ADSC component extract | Applying 1.2 g of allogeneic human adipose-derived stem cell component extract on their scalp for 16 weeks | Androgenic alopecia | Completed | Pusan National University Hospital, South Korea | NCT02594046 2015–2017 |
| 3 | “Adipose Tissue Derived Stem Cell Based Hair Restoration Therapy for Androgenetic Alopecia” | Autologous MSC and human platelet-rich plasma | MSCs derived from adipose tissue with human platelet-rich plasma will be applied | Androgenic alopecia | Not yet recruiting | King Edward Medical University, Pakistan | NCT02865421 |
| 4 | “Biocellular-Cellular Regenerative Treatment Scaring Alopecia and Alopecia Areata” | High-density platelet-rich plasma and adipose-derived tissue stromal vascular fraction (AD-tSVF) | Use of high-density platelet-rich plasma concentrates and cell-enriched emulsified adipose-derived tissue stromal vascular fraction (AD-tSVF) via intravenous infusion | Alopecia areata, scarring alopecia | Recruiting | Regeneris Medical, Global Alliance for Regenerative Medicine, Healeon Medical Inc., USA | NCT03078686 2017–2019 |
| 5 | “AGA Biocellular Stem/Stromal Hair Regenerative Study” | Adipose-derived tissue stromal vascular fraction (AD-tSVF) and high-density platelet-rich plasma | Biocellular mixture of emulsified AD-tSVF and high-density platelet-rich plasma concentrate (HD-PRP) as compared with adipose-derived cell-enriched SVF (AD-cSVF)+AD-tSVF and HD-PRP using Healeon Centricyte 1000 system and intradermal injections | Androgenetic alopecia, female pattern hair loss | Recruiting | Healeon Medical Inc., Ministry of Health, Honduras Irvine, California, USA | NCT02849470 2016–2018 |
| 6 | “Point-of-Care Adipose-derived Cells for Hair Growth” | Stromal vascular fraction (SVF) cells | A single injection into the scalp of autologous adipose-derived SVF cells | Androgenic alopecia | Recruiting | University of Florida Gainesville, Florida, USA | NCT02729415 2016-2017 |
|
